Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients
The intestinal microbiota is an “invisible organ” in the human body, with diverse components and complex interactions. Homeostasis of the intestinal microbiota plays a pivotal role in maintaining the normal physiological process and regulating immune homeostasis. By reviewing more than one hundred r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2023/3080969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849405898083008512 |
|---|---|
| author | Zhaoyi Pan Nanping Wu Changzhong Jin |
| author_facet | Zhaoyi Pan Nanping Wu Changzhong Jin |
| author_sort | Zhaoyi Pan |
| collection | DOAJ |
| description | The intestinal microbiota is an “invisible organ” in the human body, with diverse components and complex interactions. Homeostasis of the intestinal microbiota plays a pivotal role in maintaining the normal physiological process and regulating immune homeostasis. By reviewing more than one hundred related studies concerning HIV infection and intestinal microbiota from 2011 to 2023, we found that human immunodeficiency virus (HIV) infection can induce intestinal microbiota dysbiosis, which not only worsens clinical symptoms but also promotes the occurrence of post-sequelae symptoms and comorbidities. In the early stage of HIV infection, the intestinal mucosal barrier is damaged and a persistent inflammatory response is induced. Mucosal barrier damage and immune injury play a pivotal role in promoting the post-sequelae symptoms caused by HIV infection. This review summarizes the relationship between dysbiosis of the intestinal microbiota and mucosal barrier damage during HIV infection and discusses the potential mechanisms of intestinal barrier damage induced by intestinal microbiota dysbiosis and inflammation. Exploring these molecular mechanisms might provide new ideas to improve the efficacy of HIV treatment and reduce the incidence of post-sequelae symptoms. |
| format | Article |
| id | doaj-art-4e92563aa35d4083b9bdffd4530a2df0 |
| institution | Kabale University |
| issn | 1918-1493 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-4e92563aa35d4083b9bdffd4530a2df02025-08-20T03:36:34ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932023-01-01202310.1155/2023/3080969Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected PatientsZhaoyi Pan0Nanping Wu1Changzhong Jin2Jinan Microecological Biomedicine Shandong LaboratoryJinan Microecological Biomedicine Shandong LaboratoryJinan Microecological Biomedicine Shandong LaboratoryThe intestinal microbiota is an “invisible organ” in the human body, with diverse components and complex interactions. Homeostasis of the intestinal microbiota plays a pivotal role in maintaining the normal physiological process and regulating immune homeostasis. By reviewing more than one hundred related studies concerning HIV infection and intestinal microbiota from 2011 to 2023, we found that human immunodeficiency virus (HIV) infection can induce intestinal microbiota dysbiosis, which not only worsens clinical symptoms but also promotes the occurrence of post-sequelae symptoms and comorbidities. In the early stage of HIV infection, the intestinal mucosal barrier is damaged and a persistent inflammatory response is induced. Mucosal barrier damage and immune injury play a pivotal role in promoting the post-sequelae symptoms caused by HIV infection. This review summarizes the relationship between dysbiosis of the intestinal microbiota and mucosal barrier damage during HIV infection and discusses the potential mechanisms of intestinal barrier damage induced by intestinal microbiota dysbiosis and inflammation. Exploring these molecular mechanisms might provide new ideas to improve the efficacy of HIV treatment and reduce the incidence of post-sequelae symptoms.http://dx.doi.org/10.1155/2023/3080969 |
| spellingShingle | Zhaoyi Pan Nanping Wu Changzhong Jin Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients |
| title_full | Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients |
| title_fullStr | Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients |
| title_full_unstemmed | Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients |
| title_short | Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients |
| title_sort | intestinal microbiota dysbiosis promotes mucosal barrier damage and immune injury in hiv infected patients |
| url | http://dx.doi.org/10.1155/2023/3080969 |
| work_keys_str_mv | AT zhaoyipan intestinalmicrobiotadysbiosispromotesmucosalbarrierdamageandimmuneinjuryinhivinfectedpatients AT nanpingwu intestinalmicrobiotadysbiosispromotesmucosalbarrierdamageandimmuneinjuryinhivinfectedpatients AT changzhongjin intestinalmicrobiotadysbiosispromotesmucosalbarrierdamageandimmuneinjuryinhivinfectedpatients |